Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Patient With Histologically Confirmed Malignancy”

63 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 63 results

Large-scale testing (Phase 3)Study completedNCT00928486
What this trial is testing

A Safety Confirmation Study on Lenalidomide With Dexamethasone In Japanese Patients With Previously Treated Multiple Myeloma

Who this might be right for
Multiple Myeloma
Celgene 25
Early research (Phase 1)UnknownNCT00688116
What this trial is testing

Study of STA-9090, Administered Twice-Weekly in Patients With Solid Tumors

Who this might be right for
Solid Tumors
Synta Pharmaceuticals Corp. 45
Early research (Phase 1)Study completedNCT02510001
What this trial is testing

MEK and MET Inhibition in Colorectal Cancer

Who this might be right for
Solid TumorColorectal Cancer
University of Oxford 82
Testing effectiveness (Phase 2)Study completedNCT05140382
What this trial is testing

AZD4573 as Monotherapy or in Combinations With Anti-cancer Agents in Patients With r/r PTCL or r/r cHL

Who this might be right for
Relapsed/Refractory Peripheral T-cell LymphomaRelapsed/Refractory Classical Hodgkins Lymphoma
AstraZeneca 52
Testing effectiveness (Phase 2)Study completedNCT01987102
What this trial is testing

Investigation of [6R] 5,10-methylenetetrahydrofolate (Arfolitixorin) as Rescue Therapy for Osteosarcoma Patients Treated With HDMTX.

Who this might be right for
Osteosarcoma
Isofol Medical AB 18
Large-scale testing (Phase 3)Looking for participantsNCT07100730
What this trial is testing

Study of TLX101-Tx Plus Standard of Care (SoC) Versus SoC Alone for the Treatment of Patients With Recurrent Glioblastoma

Who this might be right for
Neoplastic DiseaseGlioblastomaGlioblastoma (GBM)+3 more
Telix Pharmaceuticals (Innovations) Pty Limited 50
Not applicableNot Yet RecruitingNCT05480189
What this trial is testing

Effect of Zoledronic Acid Treatment on Bone-related Events in Breast Cancer Patients With Bone Metastases: a Prospective, Multicenter, Real-world Study

Who this might be right for
Histologically Confirmed Breast Cancer ,Diagnosis of Bone Metastasis
Zhejiang Cancer Hospital 1,000
Early research (Phase 1)Study completedNCT00736372
What this trial is testing

A Trial of PX-12 in Patients With a Histologically or Cytologically Confirmed Diagnosis of Advanced or Metastatic Cancer

Who this might be right for
Metastatic CancerAdvanced Cancer
Cascadian Therapeutics Inc. 14
Not applicableStudy completedNCT01278147
What this trial is testing

Cancer Fatigue Education Program

Who this might be right for
Patient With Histologically Confirmed Malignancy
Institut de Cancérologie de la Loire 200
Early research (Phase 1)Study completedNCT00338026
What this trial is testing

A Phase I Study of ECO-4601 in Patients With Advanced Cancer

Who this might be right for
TumorsGliomaColorectal Cancer+5 more
Thallion Pharmaceuticals 26
Large-scale testing (Phase 3)Study completedNCT00473343
What this trial is testing

Metvix PDT in Participant With "High Risk" Basal Cell Carcinoma

Who this might be right for
Basal Cell Carcinoma
Galderma R&D 102
Testing effectiveness (Phase 2)Study completedNCT00409214
What this trial is testing

Phase IIa Safety and Light Dose-escalation Study in Patients With Primary or Recurrent/High-grade Glioma Using the Litx™ System to Confirm the Zone of Tumor Destruction During the Intraoperative Treatment of Glioma

Who this might be right for
GliomaGlioblastoma MultiformeAnaplastic Astrocytoma
Light Sciences Oncology 18
Not applicableNo Longer AvailableNCT03311542
What this trial is testing

Expanded Access for Pembrolizumab (MK-3475)

Who this might be right for
Melanoma (Skin)Melanoma RecurrentGlioblastoma Multiforme+2 more
Center Trials & Treatment
Early research (Phase 1)Study completedNCT01202032
What this trial is testing

Multicenter Dose-escalation Study of a Combination of Pazopanib and Bevacizumab in Patients With Metastatic Renal Cell Carcinoma or Others Advanced Solid Tumors

Who this might be right for
Metastatic Renal Cell CarcinomaAdvanced Refractory Solid Tumors Histologically or Cytologically Confirmed
Centre Leon Berard 36
Large-scale testing (Phase 3)Study completedNCT02599402
What this trial is testing

Nivolumab Combined With Ipilimumab Followed by Nivolumab Monotherapy as First-Line Treatment for Patients With Advanced Melanoma

Who this might be right for
Melanoma
Bristol-Myers Squibb 533
Early research (Phase 1)Ended earlyNCT04990479
What this trial is testing

Nous-PEV: a Novel Immunotherapy for Lung Cancer and Melanoma

Who this might be right for
Melanoma (Skin)Non-Small-Cell Lung Carcinoma
Nouscom SRL 7
Early research (Phase 1)Ended earlyNCT01278849
What this trial is testing

An Open-label, Dose Escalation Study to Assess the Pharmacokinetics of of ASA404 in Adult Cancer Patients With Impaired Hepatic Function

Who this might be right for
Histologically-proven and Radiologically-confirmed Solid Tumors
Novartis Pharmaceuticals 5
Early research (Phase 1)Study completedNCT00687934
What this trial is testing

Study of STA-9090, Administered Once-Weekly in Patients With Solid Tumors

Who this might be right for
Solid Tumors
Synta Pharmaceuticals Corp. 53
Large-scale testing (Phase 3)Looking for participantsNCT06750419
What this trial is testing

89Zr-TLX250 for PET/CT Imaging of ccRCC - ZIRCON-CP Study

Who this might be right for
Clear Cell Renal Cell Carcinoma
Telix Pharmaceuticals (Innovations) Pty Limited 82
Testing effectiveness (Phase 2)Study completedNCT00171587
What this trial is testing

Study of the Safety, Tolerability, Pharmacokinetics, and Anti-tumor Effects of Vatalanib in Combination With Capecitabine in Patients With Advanced Cancer

Who this might be right for
TumorsNeoplasm Metastasis
Novartis 22
Next Page